Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Nicholas J. Evennett"'
Autor:
Rinki Murphy, Lindsay D. Plank, Michael G. Clarke, Nicholas J. Evennett, James Tan, David D.W. Kim, Richard Cutfield, Michael W.C. Booth
Publikováno v:
Diabetes Care. 45:1503-1511
OBJECTIVE To determine whether silastic ring laparoscopic Roux-en-Y gastric bypass (SR-LRYGB) or laparoscopic sleeve gastrectomy (LSG) produces superior diabetes remission at 5 years. RESEARCH DESIGN AND METHODS In a single-center, double-blind trial
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 8, Iss 2 (2020)
BMJ Open Diabetes Research & Care
BMJ Open Diabetes Research & Care
IntroductionIn people accepted onto a bariatric surgery program we compared diabetes-related outcomes in those who completed surgery with those who withdrew before having surgery—examining rates of insulin use in people with type 2 diabetes (T2D),
Autor:
Tamasin Taylor, Yijiao Wang, William Rogerson, Grant Beban, Cindy Sharon, Lynda Bavin, Tim Cundy, Greg Gamble, Nicholas J. Evennett
Publikováno v:
Obesity Surgery. 28:2500-2507
Factors such as ethnicity, gender, and socioeconomic status may play a role in both access to and attrition from bariatric programs before surgery is undertaken. New Zealand (NZ) has high rates of obesity in its Pacific population and the indigenous
Autor:
Nicholas J. Evennett, S. John Robinson, M. Lee Humphreys, Rinki Murphy, M Clarke, Michael Booth, Richard Cutfield, Bronwen Jones, Malcolm H Johnson, David D W Kim, Hisham Hammodat, Lindsay D. Plank
Publikováno v:
Obesity Surgery. 28:293-302
There are very few randomised, blinded trials comparing laparoscopic sleeve gastrectomy (LSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB) in achieving remission of type 2 diabetes (T2D), particularly silastic ring (SR)-LRYGB. We compared the
Autor:
Cherie Blenkiron, Anthony R. J. Phillips, Maxim S. Petrov, Jiwon Hong, Nicholas J. Evennett, Eileen Gilder, Yannan Jiang, John A. Windsor, Michael Gillham
Publikováno v:
Journal of Surgical Research. 211:21-29
Background Nonocclusive mesenteric ischemia can cause intestinal infarction but the diagnosis is challenging. This prospective study evaluated three plasma biomarkers of intestinal infarction after cardiac surgery. Materials and methods Patients were
Autor:
Nicholas J. Evennett, Rishi Ram, Hannah Collins, John A. Windsor, David Orr, Grant Beban, Benjamin Loveday
Publikováno v:
Obesity surgery. 30(1)
Asymptomatic liver disease is common in bariatric patients and can be diagnosed with intraoperative biopsy. This study aimed to establish the risk-benefit profile of routine liver biopsy, prevalence of clinically significant liver disease, relationsh
Publikováno v:
Obesity surgery. 29(7)
Our primary aim was to determine whether non-attendance at pre-operative clinics were associated with non-attendance at post-operative clinics and its influence on weight loss. We also sought to examine the relationship between gender, ethnicity and
Autor:
John A. Windsor, Sanjay Pandanaboyana, Anthony R. J. Phillips, Nicholas J. Evennett, Hussam Al-Diery, Michael Gilham
Publikováno v:
Journal of intensive care medicine. 34(10)
Nonocclusive mesenteric ischemia (NOMI) is a condition that can encompass ischemia, inflammation, and infarction of the intestinal wall. In contrast to most patients with acute mesenteric ischemia, NOMI is distinguished by patent arteries and veins.
Publikováno v:
Journal of Surgical Research. 191:323-330
Background Despite emergence of markers of intestinal mucosal damage such as intestinal fatty-acid binding protein (i-FABP), there are no specific markers of damage extending into the muscle layers. We hypothesized that smooth muscle actin (SMA) rele
Autor:
Siva T, Gounder, Delendra Rasith, Wijayanayaka, Rinki, Murphy, Delwyn, Armstrong, Richard G, Cutfield, David Dw, Kim, Michael Graham, Clarke, Nicholas J, Evennett, Martyn Lee, Humphreys, Steven John, Robinson, Michael Wc, Booth
Publikováno v:
The New Zealand medical journal. 129(1443)
To provide a longitudinal analysis of the direct healthcare costs of providing laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) surgery service in the context of a randomised control trial (RCT) of obese patient